The risk of CRC in adults with CF is 5–10 times greater than the general population and is associated with carrier status for the more severe CFTR mutations, (classes I, II, and III) compared to the milder classes (IV and V) which have residual CFTR function. The gene discussed is CFTR; the disease is colorectal carcinoma.